Indicated for: bacterial infections
Route of administration: injectable
Substance: cefoperazone + sulbactam (cephalosporin antibiotic + beta-lactam antibiotic)
ATC: J01CR50 (Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors)
Cefoperazone in combination with sulbactam is used to treat severe bacterial infections, including respiratory infections, intra-abdominal infections, urinary tract infections, and sepsis. Sulbactam is a beta-lactamase inhibitor that protects cefoperazone from enzymatic degradation, thereby extending its spectrum of activity.
This combination is administered intravenously or intramuscularly, and the dosage is adjusted based on the severity of the infection and the patient's condition. It is commonly used in hospitals for complicated infections or for patients at high risk of severe infections.
Patients should be closely monitored during treatment to detect potential side effects, such as allergic reactions, diarrhea, or liver toxicity. It is important for patients to complete the treatment as directed by their doctor.
Side effects may include nausea, diarrhea, skin rashes, or, in rare cases, severe reactions such as anaphylactic shock or hematological disorders. Patients should inform their doctor of any unusual symptoms.